LASSS Compound Could Protect a Key Muscle Repair Signal

Medically reviewed | Published: | Evidence level: 1A
Researchers found that lipoic acid trisulfide, known as LASSS, protected hepatocyte growth factor from chemical damage and increased its receptor binding in laboratory experiments. LASSS also reduced HGF nitration in a mouse model of muscle disuse, but it has not been shown to prevent age-related muscle loss or improve strength in humans.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Research

Quick Facts

Compound
Lipoic acid trisulfide
Laboratory Result
More than twofold binding
Evidence Stage
Preclinical research only

How Could LASSS Support Muscle Repair?

Quick answer: LASSS may protect and enhance HGF, a signaling protein that helps activate muscle satellite cells after injury or mechanical stress.

Skeletal muscle contains satellite cells that normally remain inactive beside muscle fibers until damage or mechanical stimulation initiates repair. Hepatocyte growth factor, or HGF, helps awaken these cells by binding to the c-Met receptor, allowing them to proliferate and contribute to muscle regeneration.

HGF can lose activity through nitration, a chemical modification associated with reactive nitrogen species. The Kyushu University researchers tested two sulfur-containing trisulfides and found that LASSS reduced nitration at important sites on HGF. At the higher concentration studied, LASSS also increased HGF binding to c-Met to more than twice the level observed with untreated HGF in a laboratory assay.

What Did the Mouse Experiments Actually Show?

Quick answer: LASSS reduced chemical damage to HGF in a mouse model of muscle disuse, but the experiments did not establish a treatment for sarcopenia.

The researchers evaluated LASSS in mice subjected to tail suspension, an established experimental method for producing short-term muscle unloading. Mice receiving LASSS had less HGF nitration around muscle tissue than untreated animals, supporting the possibility that the compound can remain biologically active after oral administration.

Important limitations remain. The experiment used a disuse model rather than naturally aged animals, and reduced HGF nitration does not by itself prove that LASSS preserves muscle mass, restores strength or improves physical function. Studies in older animals must establish dosing, safety and meaningful functional outcomes before human trials would be justified.

Could LASSS Become a Treatment for Age-Related Muscle Loss?

Quick answer: LASSS is a potential drug-development lead, but it is far too early to consider it a proven or available treatment.

Age-related muscle decline involves many interacting processes, including reduced activity, altered protein metabolism, inflammation, hormonal changes and impaired regenerative signaling. Protecting HGF would therefore address only one part of a complex condition. Researchers must also determine whether strengthening this growth-factor pathway produces unintended effects elsewhere in the body.

LASSS is not an approved medicine or a supplement with demonstrated benefits for muscle aging. Until clinical evidence becomes available, resistance exercise, adequate nutrition and appropriate medical assessment remain the practical foundations of preserving muscle function. Progressive weakness, repeated falls or difficulty performing everyday activities should prompt evaluation for sarcopenia and other treatable causes.

Frequently Asked Questions

No. LASSS is an experimental compound studied in laboratory systems and mice. Its safety, effective dose and clinical benefits in people have not been established.

No. The reported mouse experiment showed reduced nitration of the HGF repair signal during short-term muscle unloading. It did not demonstrate reversal of aging or confirm improvements in muscle mass or strength.

Hepatocyte growth factor is a signaling protein that binds to the c-Met receptor and helps activate satellite cells, which participate in skeletal muscle maintenance and regeneration.

References

  1. Zushi K, et al. Enhanced HGF with increased receptor affinity and nitration-dysfunction resistance through interaction with lipoic acid trisulfide. Scientific Reports. 2026;16(1). doi:10.1038/s41598-026-60835-w.
  2. Kyushu University. Scientists discover a compound that could supercharge aging muscle repair. ScienceDaily. July 24, 2026.